The present and future of combination chemotherapy in bladder cancer

被引:14
作者
Culine, S [1 ]
机构
[1] CRLC Val Aurelle, Dept Med, F-34298 Montpellier 5, France
关键词
D O I
10.1053/sonc.2002.34271
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:32 / 39
页数:8
相关论文
共 67 条
[1]  
ALBERS P, 2000, P AN M AM SOC CLIN, V19, pA346
[2]  
[Anonymous], 1999, Lancet, V354, P533
[3]   Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy [J].
Bajorin, DF ;
Dodd, PM ;
Mazumdar, M ;
Fazzari, M ;
McCaffrey, JA ;
Scher, HI ;
Herr, H ;
Higgins, G ;
Boyle, MG .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3173-3181
[4]  
Bajorin DF, 2000, CANCER, V88, P1671, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1671::AID-CNCR22>3.0.CO
[5]  
2-A
[6]   Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial [J].
Bajorin, DF ;
McCaffrey, JA ;
Hilton, S ;
Mazumdar, M ;
Kelly, WK ;
Scher, HI ;
Spicer, J ;
Herr, H ;
Higgins, G .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2722-2727
[7]  
Bauer J, 1998, P AN M AM SOC CLIN, V17, p326a
[8]   Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium [J].
Bellmunt, J ;
Guillem, V ;
Paz-Ares, L ;
González-Larriba, JL ;
Carles, J ;
Batiste-Alentorn, E ;
Sáenz, A ;
López-Brea, M ;
Font, A ;
Nogué, M ;
Bastús, R ;
Climent, MA ;
de la Cruz, JJ ;
Albanell, J ;
Banús, JM ;
Gallardo, E ;
Diaz-Rubio, E ;
Cortés-Funes, H ;
Baselga, J .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) :3247-3255
[9]   M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR ADVANCED-CARCINOMA OF THE BLADDER - THE FRENCH FEDERATION OF CANCER CENTERS EXPERIENCE [J].
BOUTANLAROZE, A ;
MAHJOUBI, M ;
DROZ, JP ;
CHARROT, P ;
FARGEOT, P ;
KERBRAT, P ;
CATY, A ;
VOISIN, PM ;
SPIELMANN, M ;
REY, A ;
GIRAUD, B .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) :1690-1694
[10]  
BROOME CM, 2000, P AN M AM SOC CLIN, V19, pA351